This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Schmidt, H. H.-J. Articles by Brabant, G. Search for Related Content PubMed PubMed Citation Articles by Schmidt, H. H.-J. Articles by Brabant, G.

Dyslipemia in Familial Partial Lipodystrophy Caused by an R482W Mutation in the LMNA Gene

Charité Campus Mitte, Medizinische Klinik Gastroenterologie, Hepatologie und Endokrinologie (H.H.-J.S., J.G., P.B., M.P., C.B., H.L.), 10098 Berlin, Germany; Abteilung Klinische Endokrinologie (M.S., G.B.) und Abteilung Gastroenterologie und Hepatologie (J.O., U.J.F.T., M.P.M.), Medizinische Hochschule Hannover, 30623 Hannover, Germany

Address all correspondence and requests for reprints to: Dr. Hartmut Schmidt, Med. Klinik Gastroenterologie, Hepatologie, und Endokrinologie, Humboldt Universität, Charité Campus Mitte, 10098 Berlin, Germany. E-mail: hartmut.schmidt{at}charite.de

Lipatrophic diabetes, also referred to as familial partial lipodystrophy, is a rare disease that is metabolically characterized by hypertriglyceridemia and insulin resistance. Affected patients typically present with regional loss of body fat and muscular hypertrophic appearance. Variable symptoms may comprise pancreatitis and/or eruptive xanthomas due to severe hypertriglyceridemia, acanthosis nigricans, polycystic ovaria, and carpal tunnel syndrome. Mutations within the LMNA gene on chromosome 1q21.2 were recently reported to result in the phenotype of familial partial lipodystrophy. The genetic trait is autosomal dominant. We identified a family with partial lipodystrophy carrying the R482W (Arg⁴⁸²Trp) missense mutation within LMNA. Here we present the lipoprotein characteristics in this family in detail. Clinically, the loss of sc fat and muscular hypertrophy especially of the lower extremities started as early as in childhood. Acanthosis and severe hypertriglyceridemia developed later in life, followed by diabetes. The characterization of the lipoprotein subfractions revealed that affected children present with hyperlipidemia. The presence and severity of hyperlipidemia seem to be influenced by age, apolipoprotein E genotype, and the coexistence of diabetes mellitus. In conclusion, dyslipemia is an early and prominent feature in the presented lipodystrophic family carrying the R482W mutation within LMNA.

This article has been cited by other articles:

				A. Ludtke, J. Buettner, H. H-J Schmidt, and H. J Worman New PPARG mutation leads to lipodystrophy and loss of protein function that is partially restored by a synthetic ligand J. Med. Genet., September 1, 2007; 44(9): e88 - e88. [Abstract] [Full Text] [PDF]

				A. Ludtke, J. Buettner, W. Wu, A. Muchir, A. Schroeter, S. Zinn-Justin, S. Spuler, H. H.-J. Schmidt, and H. J. Worman Peroxisome Proliferator-Activated Receptor-{gamma} C190S Mutation Causes Partial Lipodystrophy J. Clin. Endocrinol. Metab., June 1, 2007; 92(6): 2248 - 2255. [Abstract] [Full Text] [PDF]

				S. Spuler, T. Kalbhenn, J. Zabojszcza, F.K.H. van Landeghem, A. Ludtke, K. Wenzel, M. Koehnlein, M. Schuelke, L. Ludemann, and H. H. Schmidt Muscle and nerve pathology in Dunnigan familial partial lipodystrophy Neurology, February 27, 2007; 68(9): 677 - 683. [Abstract] [Full Text] [PDF]

				I. Lemieux Energy Partitioning in Gluteal-Femoral Fat: Does the Metabolic Fate of Triglycerides Affect Coronary Heart Disease Risk? Arterioscler. Thromb. Vasc. Biol., May 1, 2004; 24(5): 795 - 797. [Full Text]

				K. L. Herbst, L. R. Tannock, S. S. Deeb, J. Q. Purnell, J. D. Brunzell, and A. Chait Kobberling Type of Familial Partial Lipodystrophy: An underrecognized syndrome Diabetes Care, June 1, 2003; 26(6): 1819 - 1824. [Abstract] [Full Text] [PDF]

				H. H.-J. Schmidt and R. A. Hegele Consider Cardiomyopathy in Subjects With Familial Partial Lipodystrophy Response Circulation, January 15, 2002; 105 (2): e7 - e7. [Full Text] [PDF]